CIRILLO, I., A. VIZZACCARO, and E. CRIMI. Airway Reactivity and Diving in Healthy and Atopic Subjects. Med. Sci. Sports Everc., Vol. 35, No. 9, pp. 1493-1498, 2003. Background: The short- and long-term effects of self-contained underwater breathing apparatus (SCUBA) dives on airway responsiveness in nonasthmatic atopic subjects have not been systematically investigated. Purpose: To compare the effect of SCUBA diving at 50-m depth on lung function and airway responsiveness to methacholine (MCh) in atopic nonasthmatics and healthy subjects. Methods: We studied 15 atopic nonasthmatic subjects and 15 controls who underwent the visit for the professional SCUBA-diving license at the Navy Medical Center. La Spezia, Italy. All subjects underwent spirometry and skin-prick test for common environmental allergens. MCh challenge was performed 24 h before. and 20 min and 24 h after a standardized SCUBA-dive test and after hyperbaric-chamber test. Results: At 20 min, the provocative dose of MCh causing 20% fall of the forced expiratory volume at the first second (MCh PD20 - FEV1) was significantly reduced in atopic, asymptomatic subjects from 1712 x 2.6 mug (mean x geometric standard deviation) to 1202 x 2.2 mug (P < 0.0005) after the hyperbaric-chamber test and to 1204 x 2.3 mug (P < 0.005) after SCUBA diving. In healthy subjects, the baseline value of MCh PD20 was 2977 x 1.1 mug, and this value did not change significantly after the hyperbaric-chamber test (2575 x 1.4 mug) and after SCUBA dives (2553 x 1.4 mug, P > 0.1 for both comparisons). In atopic subjects, the MCh PD20 returned near to the baseline value 24 h alter the hyperbaric-chamber test (1776 x 2.4 mug) and after the SCUBA test (1500 x 2.67 mug). No significant change in FEV, was observed after the tests in both groups. Conclusion: SCUBA diving is associated with development of early airway hyperresponsiveness to MCh in atopic Subjects.